This suggests that rosmarinic acid can reduce neuroinflammation by inhibiting the TLR4/NF-κB/HMGB1 pathway, potentially demonstrating its anti-PD efficacy (Figure 2)80. Here, NFKB1 is linked to Parkinson disease.